Alpha Blue Ocean operates through a direct, rational, and efficient approach in providing alternative financing solutions through PIPE (Private Investments in Public Equities) deals. ABO has made notable investments in companies such as AB Science (AB:FP), Erytech (ERYP:US), Wisekey (WKEY:US), Intrasense (ALINS:FP), and DBT Group (ALDBT:FP), among others.

Disclaimer

This press release contains certain forward-looking statements concerning Pharnext and its business, including in respect of timing of and prospects for clinical trials and regulatory submissions of the Company's product candidates as well as a potential financing transaction, the use of proceeds therefrom and cash runway. Such forward-looking statements are based on assumptions that Pharnext considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in Pharnext's URD approved by the AMF on November 9, 2020 under number N° R. 20-029 as well as in its annual periodic management reports and press releases (copies of which are available on www.pharnext.com) and to the development of economic conditions, financial markets and the markets in which Pharnext operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Pharnext or not currently considered material by Pharnext. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Pharnext to be materially different from such forward-looking statements. Pharnext disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.]

This press release and the information that it contains do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, Pharnext shares in any country, including the United States. The Company's securities may not be offered or sold in the United States absent registration or an exemption from registration; any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the issuer that will contain detailed information about the Company and management, as well as financial statements.

Contacts 


David Horn Solomon 
Chief Executive Officer 
contact@pharnext.com 
+33 (0)1 41 09 22 30 
 
                                                                    Media Relations (France) 
Media Relations (International) 
                                   Financial Communication (Europe) Ulysse Communication 
Consilium Strategic Communications 
                                   Actifin                          Bruno Arabian 
Mary-Jane Elliott 
                                   Ghislaine Gasparetto             barabian@ulysse-communication.com 
Sukaina Virji 
                                   ggasparetto@actifin.fr           +33 (0)6 87 88 47 26 
Alexandra Harrison 
                                   +33 (0)6 21 10 49 24             +33 (0)1 81 70 96 30 
pharnext@consilium-comms.com 
 -----------------------------------------------------------------------------------------------------------------------

[1] Theoretical calculations on the basis of a conversion price equal to 94% of the lowest daily VWAP (as published by Bloomberg) during the fifteen (15) trading days preceding the date hereof i.e. EUR2.745 x 94% = 2.58. ----------------------------------------------------------------------------------------------------------------------- Regulatory filing PDF file File: Financing Release

1204675 07-Jun-2021 CET/CEST


 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1204675&application_name=news

(END) Dow Jones Newswires

June 07, 2021 02:01 ET (06:01 GMT)